Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "new"

5592 News Found

Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India
interviews | May 25, 2026

Nexis GC-2060 is Shimadzu's new flagship gas chromatograph system: Dheeraj Handique, Manager - Sales & Marketing, Analytical Division, Shimadzu India

Nexis GC-2060 replaces legacy baselines by introducing advanced automated workflows, expanded modularity, and enhanced detector sensitivity designed to minimize laboratory downtime


Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026
R&D | May 25, 2026

Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026

Highlights strong Vibegron results in older men & real-world prostate cancer insights


IGI’s new drug candidate ISB 2301 to target solid tumors
Biopharma | May 20, 2026

IGI’s new drug candidate ISB 2301 to target solid tumors

The company intends to file an IND submission by the end of this year and begin clinical studies in 2027


Novartis locks in $23 billion US expansion with seventh new facility
News | May 05, 2026

Novartis locks in $23 billion US expansion with seventh new facility

The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics


Eton Pharmaceuticals relaunches HEMANGEOL with new distribution model
News | May 05, 2026

Eton Pharmaceuticals relaunches HEMANGEOL with new distribution model

The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy


Health ministry releases new healthcare safety guidelines
Policy | May 04, 2026

Health ministry releases new healthcare safety guidelines

Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities


FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
News | May 02, 2026

FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win

The renewal covers two versions of the IQOS device and three HEETS tobacco variants


Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi
Hospitals | May 01, 2026

Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi

The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries


India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework
Policy | April 30, 2026

India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework

Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services